32 related articles for article (PubMed ID: 7664273)
1. Cellular senescence and neurodegeneration.
Holloway K; Neherin K; Dam KU; Zhang H
Hum Genet; 2023 Aug; 142(8):1247-1262. PubMed ID: 37115318
[TBL] [Abstract][Full Text] [Related]
2. The KDM4A/KDM4C/NF-κB and WDR5 epigenetic cascade regulates the activation of B cells.
Hung KH; Woo YH; Lin IY; Liu CH; Wang LC; Chen HY; Chiang BL; Lin KI
Nucleic Acids Res; 2018 Jun; 46(11):5547-5560. PubMed ID: 29718303
[TBL] [Abstract][Full Text] [Related]
3. The Role of
Turgut S; Ilhan M; Turan S; Karaman O; Yaylim I; Kucukhuseyin O; Tasan E
In Vivo; 2017; 31(3):357-363. PubMed ID: 28438863
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cells in aging and disease.
Limke TL; Rao MS
J Cell Mol Med; 2002; 6(4):475-96. PubMed ID: 12611637
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
6. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.
Sakashita K; Koike K; Kinoshita T; Shiohara M; Kamijo T; Taniguchi S; Kubota T
J Clin Invest; 2001 Oct; 108(8):1195-204. PubMed ID: 11602627
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.
Schoppmeyer K; Norris PS; Haas M
Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047
[TBL] [Abstract][Full Text] [Related]
8. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
9. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
[TBL] [Abstract][Full Text] [Related]
10. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells.
Schwartz B; Avivi-Green C; Polak-Charcon S
Mol Cell Biochem; 1998 Nov; 188(1-2):21-30. PubMed ID: 9823007
[TBL] [Abstract][Full Text] [Related]
12. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.
Wang J; Walsh K
Science; 1996 Jul; 273(5273):359-61. PubMed ID: 8662523
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644
[TBL] [Abstract][Full Text] [Related]
14. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Stone S; Dayananth P; Jiang P; Weaver-Feldhaus JM; Tavtigian SV; Cannon-Albright L; Kamb A
Oncogene; 1995 Sep; 11(5):987-91. PubMed ID: 7675459
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
16. [Cyclin-dependent kinase inhibitors in mammal cells].
Jiang H; Wang YC
Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
[TBL] [Abstract][Full Text] [Related]
17. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.
Siebert R; Willers CP; Opalka B
Leuk Lymphoma; 1996 Nov; 23(5-6):505-20. PubMed ID: 9031081
[TBL] [Abstract][Full Text] [Related]
18. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation.
Lois AF; Cooper LT; Geng Y; Nobori T; Carson D
Cancer Res; 1995 Sep; 55(18):4010-3. PubMed ID: 7664273
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
